Discover
CRNX
Crinetics Pharmaceuticals, Inc.
84.30
8 x 84.29
2 x 84.30
bid
ask
+
0.14
0.17%
01:41 PM
timesize
| Ytd | 81.08% | |
| 1y | 207.87% |
84.20
day range
84.34
27.52
52 week range
84.34
| Open | 84.25 | Prev Close | 84.15 | Low | 84.20 | High | 84.34 | Mkt Cap | 8.93B |
| Vol | 906.79K | Avg Vol | 3.75M | EPS | -5.04 | P/E | -16.73 | Forward P/E | -20.65 |
| Beta | 0.12 | Short Ratio | 0.84 | Inst. Own | 122.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 59.74 | 200-d Avg | 47.26 | 1yr Est | 85.50 |
| Income Statement | |||
| Total Revenue | 25.12M | ||
| Revenues (USD) | 25.12M | ||
| Cost of Revenue | 154.00K | ||
| Gross Profit | 24.96M | ||
| Operating Expenses | 157.42M | ||
| Research and Development Expense | 99.85M | ||
| Selling, General and Administrative Expense | 57.57M | ||
| Operating Income | -132.46M | ||
| Net Income | -120.85M | ||
| Net Income Common Stock | -120.85M | ||
| Net Income Common Stock (USD) | -120.85M | ||
| Consolidated Income | -120.85M | ||
| Earnings per Basic Share | -1.14 | ||
| Earnings per Basic Share (USD) | -1.14 | ||
| Earnings per Diluted Share | -1.14 | ||
| Earning Before Interest & Taxes (EBIT) | -120.85M | ||
| Earning Before Interest & Taxes (USD) | -120.85M | ||
| Weighted Average Shares | 105.56M | ||
| Weighted Average Shares Diluted | 105.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 55.50M | ||
| Cash and Equivalents (USD) | 55.50M | ||
| Investments | 1.15B | ||
| Investments Current | 1.15B | ||
| Investments Non-Current | 800.00K | ||
| Trade and Non-Trade Receivables | 11.96M | ||
| Current Assets | 1.24B | ||
| Property, Plant & Equipment Net | 52.18M | ||
| Total Assets | 1.32B | ||
| Debt Current | 6.59M | ||
| Total Debt | 47.19M | ||
| Current Liabilities | 79.92M | ||
| Debt Non-Current | 40.61M | ||
| Total Liabilities | 129.92M | ||
| Accumulated Retained Earnings (Deficit) | -1.67B | ||
| Accumulated Other Comprehensive Income | -3.01M | ||
| Shareholders Equity | 1.19B | ||
| Shareholders Equity (USD) | 1.19B | ||
| Assets Non-Current | 77.52M | ||
| Total Debt (USD) | 47.19M | ||
| Deferred Revenue | 5.13M | ||
| Inventory | 3.49M | ||
| Liabilities Non-Current | 50.01M | ||
| Trade and Non-Trade Payables | 42.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.76M | ||
| Net Cash Flow from Financing | 8.93M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -58.97M | ||
| Capital Expenditure | -521.00K | ||
| Issuance (Purchase) of Equity Shares | 8.93M | ||
| Net Cash Flow from Investing | 26.29M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 26.81M | ||
| Net Cash Flow from Operations | -94.19M | ||
| Share Based Compensation | 24.88M | ||